West Michigan Oral Surgery | |
601 Michigan Ave Suite 200 Holland MI 49423-4951 | |
(616) 530-4710 | |
(616) 530-0480 |
Full Name | West Michigan Oral Surgery |
---|---|
Speciality | Dentist |
Location | 601 Michigan Ave, Holland, Michigan |
Authorized Official Name and Position | Jeffrey Allen Lindhout (SECRETARY TREASURER) |
Authorized Official Contact | 6165304710 |
Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
Mailing Address | Practice Location Address |
---|---|
West Michigan Oral Surgery 601 Michigan Ave Suite 200 Holland MI 49423-4951 Ph: (616) 530-4710 | West Michigan Oral Surgery 601 Michigan Ave Suite 200 Holland MI 49423-4951 Ph: (616) 530-4710 |
NPI Number | 1326197880 |
---|---|
Provider Enumeration Date | 01/10/2007 |
Last Update Date | 06/05/2008 |
Medicare PECOS PAC ID | 5193731370 |
---|---|
Medicare Enrollment ID | O20060224000400 |
News Archive
Approximately 13 percent of U.S. children have had a special health care need, and significant proportions of their families experience financial problems related to the child's condition, according to an article in the September issue of the Archives of Pediatrics & Adolescent Medicine.
Galleon Pharmaceuticals, a leader in the development of novel medicines to treat breathing disorders, today announced that its investigational drug GAL-021 appeared to be safe and well-tolerated and demonstrated dose-proportional pharmacokinetic effects on respiration in a Phase I clinical study of 30 healthy adults.
Democratic Republic of Congo is in the grip of an emergency. For two decades, persistent conflict in its eastern provinces and instability in other regions and a dysfunctional health system have led to recurrent humanitarian crises and outbreaks of disease.
Some 2.3 million children a year, mostly from low- to middle-income families, have no health care coverage to pay for preventive or other medical needs, even though at least one of their parents is insured, according to a new study supported by HHS' Agency for Healthcare Research and Quality and the National Center for Research Resources, part of HHS' National Institutes of Health.
› Verified 3 days ago
Identifier | Type | State | Issuer |
---|---|---|---|
1326197880 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1223S0112X | Dentist - Oral And Maxillofacial Surgery | (* (Not Available)) | Primary |
Provider Name | Mark J Lonergan |
---|---|
Provider Type | Practitioner - Maxillofacial Surgery |
Provider Identifiers | NPI Number: 1952384521 PECOS PAC ID: 3274549456 Enrollment ID: I20110225000886 |
News Archive
Approximately 13 percent of U.S. children have had a special health care need, and significant proportions of their families experience financial problems related to the child's condition, according to an article in the September issue of the Archives of Pediatrics & Adolescent Medicine.
Galleon Pharmaceuticals, a leader in the development of novel medicines to treat breathing disorders, today announced that its investigational drug GAL-021 appeared to be safe and well-tolerated and demonstrated dose-proportional pharmacokinetic effects on respiration in a Phase I clinical study of 30 healthy adults.
Democratic Republic of Congo is in the grip of an emergency. For two decades, persistent conflict in its eastern provinces and instability in other regions and a dysfunctional health system have led to recurrent humanitarian crises and outbreaks of disease.
Some 2.3 million children a year, mostly from low- to middle-income families, have no health care coverage to pay for preventive or other medical needs, even though at least one of their parents is insured, according to a new study supported by HHS' Agency for Healthcare Research and Quality and the National Center for Research Resources, part of HHS' National Institutes of Health.
› Verified 3 days ago
Provider Name | Paul J Huizinga |
---|---|
Provider Type | Practitioner - Maxillofacial Surgery |
Provider Identifiers | NPI Number: 1174516363 PECOS PAC ID: 7810178662 Enrollment ID: I20110226000008 |
News Archive
Approximately 13 percent of U.S. children have had a special health care need, and significant proportions of their families experience financial problems related to the child's condition, according to an article in the September issue of the Archives of Pediatrics & Adolescent Medicine.
Galleon Pharmaceuticals, a leader in the development of novel medicines to treat breathing disorders, today announced that its investigational drug GAL-021 appeared to be safe and well-tolerated and demonstrated dose-proportional pharmacokinetic effects on respiration in a Phase I clinical study of 30 healthy adults.
Democratic Republic of Congo is in the grip of an emergency. For two decades, persistent conflict in its eastern provinces and instability in other regions and a dysfunctional health system have led to recurrent humanitarian crises and outbreaks of disease.
Some 2.3 million children a year, mostly from low- to middle-income families, have no health care coverage to pay for preventive or other medical needs, even though at least one of their parents is insured, according to a new study supported by HHS' Agency for Healthcare Research and Quality and the National Center for Research Resources, part of HHS' National Institutes of Health.
› Verified 3 days ago
Provider Name | Keith A Nalley |
---|---|
Provider Type | Practitioner - Oral Surgery |
Provider Identifiers | NPI Number: 1528041605 PECOS PAC ID: 8729094909 Enrollment ID: I20110226000011 |
News Archive
Approximately 13 percent of U.S. children have had a special health care need, and significant proportions of their families experience financial problems related to the child's condition, according to an article in the September issue of the Archives of Pediatrics & Adolescent Medicine.
Galleon Pharmaceuticals, a leader in the development of novel medicines to treat breathing disorders, today announced that its investigational drug GAL-021 appeared to be safe and well-tolerated and demonstrated dose-proportional pharmacokinetic effects on respiration in a Phase I clinical study of 30 healthy adults.
Democratic Republic of Congo is in the grip of an emergency. For two decades, persistent conflict in its eastern provinces and instability in other regions and a dysfunctional health system have led to recurrent humanitarian crises and outbreaks of disease.
Some 2.3 million children a year, mostly from low- to middle-income families, have no health care coverage to pay for preventive or other medical needs, even though at least one of their parents is insured, according to a new study supported by HHS' Agency for Healthcare Research and Quality and the National Center for Research Resources, part of HHS' National Institutes of Health.
› Verified 3 days ago
Provider Name | Jeffrey A Lindhout |
---|---|
Provider Type | Practitioner - Maxillofacial Surgery |
Provider Identifiers | NPI Number: 1073506390 PECOS PAC ID: 5991711178 Enrollment ID: I20110226000018 |
News Archive
Approximately 13 percent of U.S. children have had a special health care need, and significant proportions of their families experience financial problems related to the child's condition, according to an article in the September issue of the Archives of Pediatrics & Adolescent Medicine.
Galleon Pharmaceuticals, a leader in the development of novel medicines to treat breathing disorders, today announced that its investigational drug GAL-021 appeared to be safe and well-tolerated and demonstrated dose-proportional pharmacokinetic effects on respiration in a Phase I clinical study of 30 healthy adults.
Democratic Republic of Congo is in the grip of an emergency. For two decades, persistent conflict in its eastern provinces and instability in other regions and a dysfunctional health system have led to recurrent humanitarian crises and outbreaks of disease.
Some 2.3 million children a year, mostly from low- to middle-income families, have no health care coverage to pay for preventive or other medical needs, even though at least one of their parents is insured, according to a new study supported by HHS' Agency for Healthcare Research and Quality and the National Center for Research Resources, part of HHS' National Institutes of Health.
› Verified 3 days ago
Provider Name | Corneilius W Hoekstra |
---|---|
Provider Type | Practitioner - Maxillofacial Surgery |
Provider Identifiers | NPI Number: 1114928454 PECOS PAC ID: 2365458544 Enrollment ID: I20110226000022 |
News Archive
Approximately 13 percent of U.S. children have had a special health care need, and significant proportions of their families experience financial problems related to the child's condition, according to an article in the September issue of the Archives of Pediatrics & Adolescent Medicine.
Galleon Pharmaceuticals, a leader in the development of novel medicines to treat breathing disorders, today announced that its investigational drug GAL-021 appeared to be safe and well-tolerated and demonstrated dose-proportional pharmacokinetic effects on respiration in a Phase I clinical study of 30 healthy adults.
Democratic Republic of Congo is in the grip of an emergency. For two decades, persistent conflict in its eastern provinces and instability in other regions and a dysfunctional health system have led to recurrent humanitarian crises and outbreaks of disease.
Some 2.3 million children a year, mostly from low- to middle-income families, have no health care coverage to pay for preventive or other medical needs, even though at least one of their parents is insured, according to a new study supported by HHS' Agency for Healthcare Research and Quality and the National Center for Research Resources, part of HHS' National Institutes of Health.
› Verified 3 days ago
Provider Name | Reynaldo D Rivera |
---|---|
Provider Type | Practitioner - Maxillofacial Surgery |
Provider Identifiers | NPI Number: 1790902989 PECOS PAC ID: 5395992721 Enrollment ID: I20120820001046 |
News Archive
Approximately 13 percent of U.S. children have had a special health care need, and significant proportions of their families experience financial problems related to the child's condition, according to an article in the September issue of the Archives of Pediatrics & Adolescent Medicine.
Galleon Pharmaceuticals, a leader in the development of novel medicines to treat breathing disorders, today announced that its investigational drug GAL-021 appeared to be safe and well-tolerated and demonstrated dose-proportional pharmacokinetic effects on respiration in a Phase I clinical study of 30 healthy adults.
Democratic Republic of Congo is in the grip of an emergency. For two decades, persistent conflict in its eastern provinces and instability in other regions and a dysfunctional health system have led to recurrent humanitarian crises and outbreaks of disease.
Some 2.3 million children a year, mostly from low- to middle-income families, have no health care coverage to pay for preventive or other medical needs, even though at least one of their parents is insured, according to a new study supported by HHS' Agency for Healthcare Research and Quality and the National Center for Research Resources, part of HHS' National Institutes of Health.
› Verified 3 days ago
Provider Name | Kyle Klooster |
---|---|
Provider Type | Practitioner - Oral Surgery |
Provider Identifiers | NPI Number: 1053608752 PECOS PAC ID: 8628375797 Enrollment ID: I20170609001273 |
News Archive
Approximately 13 percent of U.S. children have had a special health care need, and significant proportions of their families experience financial problems related to the child's condition, according to an article in the September issue of the Archives of Pediatrics & Adolescent Medicine.
Galleon Pharmaceuticals, a leader in the development of novel medicines to treat breathing disorders, today announced that its investigational drug GAL-021 appeared to be safe and well-tolerated and demonstrated dose-proportional pharmacokinetic effects on respiration in a Phase I clinical study of 30 healthy adults.
Democratic Republic of Congo is in the grip of an emergency. For two decades, persistent conflict in its eastern provinces and instability in other regions and a dysfunctional health system have led to recurrent humanitarian crises and outbreaks of disease.
Some 2.3 million children a year, mostly from low- to middle-income families, have no health care coverage to pay for preventive or other medical needs, even though at least one of their parents is insured, according to a new study supported by HHS' Agency for Healthcare Research and Quality and the National Center for Research Resources, part of HHS' National Institutes of Health.
› Verified 3 days ago
Provider Name | George D Kirby |
---|---|
Provider Type | Practitioner - Oral Surgery |
Provider Identifiers | NPI Number: 1770846834 PECOS PAC ID: 2264730357 Enrollment ID: I20180719001523 |
News Archive
Approximately 13 percent of U.S. children have had a special health care need, and significant proportions of their families experience financial problems related to the child's condition, according to an article in the September issue of the Archives of Pediatrics & Adolescent Medicine.
Galleon Pharmaceuticals, a leader in the development of novel medicines to treat breathing disorders, today announced that its investigational drug GAL-021 appeared to be safe and well-tolerated and demonstrated dose-proportional pharmacokinetic effects on respiration in a Phase I clinical study of 30 healthy adults.
Democratic Republic of Congo is in the grip of an emergency. For two decades, persistent conflict in its eastern provinces and instability in other regions and a dysfunctional health system have led to recurrent humanitarian crises and outbreaks of disease.
Some 2.3 million children a year, mostly from low- to middle-income families, have no health care coverage to pay for preventive or other medical needs, even though at least one of their parents is insured, according to a new study supported by HHS' Agency for Healthcare Research and Quality and the National Center for Research Resources, part of HHS' National Institutes of Health.
› Verified 3 days ago
Provider Name | Ashley Nicole Houle |
---|---|
Provider Type | Practitioner - Oral Surgery |
Provider Identifiers | NPI Number: 1235526765 PECOS PAC ID: 5395055206 Enrollment ID: I20210714001628 |
News Archive
Approximately 13 percent of U.S. children have had a special health care need, and significant proportions of their families experience financial problems related to the child's condition, according to an article in the September issue of the Archives of Pediatrics & Adolescent Medicine.
Galleon Pharmaceuticals, a leader in the development of novel medicines to treat breathing disorders, today announced that its investigational drug GAL-021 appeared to be safe and well-tolerated and demonstrated dose-proportional pharmacokinetic effects on respiration in a Phase I clinical study of 30 healthy adults.
Democratic Republic of Congo is in the grip of an emergency. For two decades, persistent conflict in its eastern provinces and instability in other regions and a dysfunctional health system have led to recurrent humanitarian crises and outbreaks of disease.
Some 2.3 million children a year, mostly from low- to middle-income families, have no health care coverage to pay for preventive or other medical needs, even though at least one of their parents is insured, according to a new study supported by HHS' Agency for Healthcare Research and Quality and the National Center for Research Resources, part of HHS' National Institutes of Health.
› Verified 3 days ago
Provider Name | Jeffrey T Deyoung |
---|---|
Provider Type | Practitioner - Oral Surgery |
Provider Identifiers | NPI Number: 1932638822 PECOS PAC ID: 8527333780 Enrollment ID: I20220915003645 |
News Archive
Approximately 13 percent of U.S. children have had a special health care need, and significant proportions of their families experience financial problems related to the child's condition, according to an article in the September issue of the Archives of Pediatrics & Adolescent Medicine.
Galleon Pharmaceuticals, a leader in the development of novel medicines to treat breathing disorders, today announced that its investigational drug GAL-021 appeared to be safe and well-tolerated and demonstrated dose-proportional pharmacokinetic effects on respiration in a Phase I clinical study of 30 healthy adults.
Democratic Republic of Congo is in the grip of an emergency. For two decades, persistent conflict in its eastern provinces and instability in other regions and a dysfunctional health system have led to recurrent humanitarian crises and outbreaks of disease.
Some 2.3 million children a year, mostly from low- to middle-income families, have no health care coverage to pay for preventive or other medical needs, even though at least one of their parents is insured, according to a new study supported by HHS' Agency for Healthcare Research and Quality and the National Center for Research Resources, part of HHS' National Institutes of Health.
› Verified 3 days ago
News Archive
Approximately 13 percent of U.S. children have had a special health care need, and significant proportions of their families experience financial problems related to the child's condition, according to an article in the September issue of the Archives of Pediatrics & Adolescent Medicine.
Galleon Pharmaceuticals, a leader in the development of novel medicines to treat breathing disorders, today announced that its investigational drug GAL-021 appeared to be safe and well-tolerated and demonstrated dose-proportional pharmacokinetic effects on respiration in a Phase I clinical study of 30 healthy adults.
Democratic Republic of Congo is in the grip of an emergency. For two decades, persistent conflict in its eastern provinces and instability in other regions and a dysfunctional health system have led to recurrent humanitarian crises and outbreaks of disease.
Some 2.3 million children a year, mostly from low- to middle-income families, have no health care coverage to pay for preventive or other medical needs, even though at least one of their parents is insured, according to a new study supported by HHS' Agency for Healthcare Research and Quality and the National Center for Research Resources, part of HHS' National Institutes of Health.
› Verified 3 days ago
Daniel D Gardner Dmd Pllc Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 181 W 35th St, Holland, MI 49423 Phone: 616-392-8668 | |
Cln Dental Pllc Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 187 Riley St, Holland, MI 49424 Phone: 616-399-1500 Fax: 616-399-8730 | |
Holland Family Dentistry Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 545 Michigan Ave, Holland, MI 49423 Phone: 616-396-1058 | |
Stout And Gordon Family Dentistry Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 12723 N Bellwood St, Suite 30, Holland, MI 49424 Phone: 616-399-8230 Fax: 616-399-8374 | |
Little Red Pediatric Dentistry, Plc Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 12723 N Bellwood Dr Ste 20, Holland, MI 49424 Phone: 616-377-7333 Fax: 616-399-8374 | |
Dental Office Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 170 College Ave, #220, Holland, MI 49423 Phone: 616-392-2302 Fax: 616-392-9060 | |
Scott Vanslambrouck Dentistry, Pc Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 455 Butternut Dr, Holland, MI 49424 Phone: 616-394-4700 Fax: 616-394-4883 |